Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN, Abdelrazek S, Szumowski P, Rogowski F, Sykała M, Kostecki J, Kociura-Sawicka A, Jurgilewicz D, Myśliwiec J.
Nucl Med Rev Cent East Eur. 2016;19(1):3-11. doi: 10.5603/NMR.2016.0002.
PMID:26841373
Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.